VINCENT MILANO
CIK 1187159 · PRESIDENT AND CEO · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.26M
Companies
7
Total Filings
98
Lifetime Open-Market Net
-$2.79M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCRX | Director | 108,483 | $9.74 | $1.06M | $185.2K | 24 | 2026-06-15 |
| ACRS | Director | 28,896 | $5.33 | $154.0K | $0 | 9 | 2026-06-08 |
| Aceragen, Inc. (ACGN) Delisted | Director | 8,987 | $0.38 | $3.4K | -$1.8K | 1 | 2023-08-11 |
| Aceragen, Inc. (IDRA) Delisted | PRESIDENT AND CEO | 12,271 | $7.22 | $88.7K | $781.5K | 22 | 2022-07-07 |
| Spark Therapeutics, Inc. (ONCE) Delisted | Director | 0 | — | — | $0 | 5 | 2019-12-17 |
| VNDA | Director | 10,000 | $5.16 | $51.6K | $0 | 9 | 2018-06-15 |
| VIROPHARMA INC (VPHM) Delisted | President and CEO | 450,898 | — | — | -$3.75M | 25 | 2014-01-21 |
Recent Filings · Page 2 of 10
98 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-02 | BCRX | Grant (A) | +750 | $5.6K | EDGAR |
| 2024-09-03 | BCRX | Grant (A) | +647 | $5.6K | EDGAR |
| 2024-06-14 | BCRX | Grant (A) | +6,820 | $0 | EDGAR |
| 2024-06-10 | ACRS | Grant (A) | — | $0 | EDGAR |
| 2024-06-04 | ACRS | Exer (M) | +4,660 | $0 | EDGAR |
| 2024-06-03 | BCRX | Grant (A) | +870 | $5.6K | EDGAR |
| 2024-05-22 | BCRX | Buy (P) | +15,000 | $93.8K | EDGAR |
| 2024-03-04 | BCRX | Grant (A) | +999 | $5.6K | EDGAR |
| 2023-12-01 | BCRX | Grant (A) | +956 | $5.6K | EDGAR |
| 2023-09-05 | BCRX | Grant (A) | +791 | $5.6K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.